Executive control functions and neuropsychiatric disorders - Perspectives for research und clinical practice;Exekutive kontrollfunktionen und neuropsychiatrische erkrankungen - Perspektiven für forschung und klinik

Fortschritte der Neurologie Psychiatrie

Volumn 73, Issue 8, 2005, Pages 438-450

  Kaiser, S ^a   Mundt, C ^a   Weisbrod, Matthias ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COGNITION; FRONTAL CORTEX; HUMAN; MOOD DISORDER; MOTOR DYSFUNCTION; NERVE CELL NETWORK; PREFRONTAL CORTEX; PROGNOSIS; SCHIZOPHRENIA;

BASAL GANGLIA DISEASES; CEREBRAL CORTEX; COGNITION; COGNITIVE THERAPY; HUMANS; MENTAL DISORDERS; MOOD DISORDERS; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; PERSONALITY DISORDERS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIC PSYCHOLOGY;

EID: 23844537412     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830303     Document Type: Article

References (203)

1. Schneider W, Shiffrin RM. Controlled and automatic human information processing I: Detection, search and attention. Psychol Rev 1977; 84: 1-66
2. Shiffrin RM, Schneider W. Controlled and automatic human information processing: II. Perceptual learning, automatic attending and a general theory. Psychol Rev 1977; 84:127-190
3. Hasher L, Zacks RT. Automatic and effortful processes in memory. J Exp Psychol Gen 1979; 108: 356-389
4. Norman DA, Shallice T. Attention to action: Willed and automatic control of behavior. In: Davidson R, Schwartz G, Shapiro D (Hrsg). Consciousness and self-regulation. New York: Plenum Press, 1986: 1-18
5. Stuss DT, Benson DF. The Frontal Lobes. New York: Raven, 1986
6. Robbins TW. Dissociating executive functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996; 351 (1346): 1463-1470
7. Stuss DT, Shallice T, Alexander MP, Picton TW. A multidisciplinary approach to anterior attentional functions. Ann N Y Acad Sci 1995; 769: 191-211
8. Shallice T, Burgess P. The domain of supervisory processes and temporal organization of behaviour. Philos Trans R Soc Lond B Biol Sci 1996; 351 (1346): 1405-1411; discussion 1411-1412
9. Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, LaFrance Jr WC, Coffey CE. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002; 14 (4): 377-405
10. Alexander GE, DeLong MR, Strick PL Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381
11. Goldman-Rakic PS. Circuitry of primate prefrontal cortex and regulation of behavior by representational knowledge. In: Plum F, Mountcastle V (Hrsg). Handbook of Physiology. Bethesda: American Physiological Society, 1987: 373-417
12. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994; 6 (4): 358-370
13. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13 (7): 266-271
14. Graybiel AM. The basal ganglia. Curr Biol 2000; 10(14): R509-511
15. Arnsten AF. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997; 11 (2): 151-162
16. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53 (2): 647-654
17. Berman KF, Ostrem JL, Randolph C, Gold J, Goldberg TE, Coppola R, Carson RE, Herscovitch P, Weinberger DR. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 1995; 33 (8): 1027-1046
18. D'Esposito M, Detre JA, Alsop DC, Shin RK, Atlas S, Grossman M. The neural basis of the central executive system of working memory. Nature 1995; 378 (6554): 279-281
19. Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 2000; 10 (3): 295-307
20. Drewe EA. Go-Nogo learning after frontal lobe lesions in humans. Cortex 1975; 11: 8-16
21. Starkstein SE, Robinson RG. Mechanism of disinhibition after brain lesions. J Nerv Ment Dis 1997; 185 (2): 108-114
22. Posner MI, DiGirolamo G. Executive attention: Conflict, target detection and cognitive control. In: Parasuraman R (Hrsg). The attentive brain. Cambridge: MIT Press, 1998: 401-423
23. Cohen RA, Kaplan RF, Moser DJ, Jenkins MA, Wilkinson H. Impairments of attention after cingulotomy. Neurology 1999; 53 (4): 819-824
24. Barch DM, Carter CS, Hachten PC, Usher M, Cohen JD. The "benefits" of distractibility: mechanisms underlying increased Stroop effects in schizophrenia. Schizophr Bull 1999; 25 (4): 749-762
25. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987; 10: 197-245
26. Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry 2003; 160(10): 1726-1739
27. Ovsiew F, Bylsma FW. The three cognitive examinations. Semin Clin Neuropsychiatry 2002; 7 (1): 54-64
28. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55 (11): 1621-1626
29. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002; 72 (1): 12-21
30. Pirozzolo FJ, Hansch EC, Mortimer JA, Webster DD, Kuskowski MA. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn 1982; 1 (1): 71-83
31. Hietanen M, Teravainen H. Cognitive performance in early Parkinson's disease. Acta Neurol Scand 1986; 73 (2): 151-159
32. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106 (Pt 2): 257-270
33. Kaasinen V, Rinne JO. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev 2002; 26 (7): 785-793
34. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet 1984; 2 (8414): 1262-1265
35. Mortimer JA, Pirozzolo FJ, Hansch EC, Webster DD. Relationship of motor symptoms to intellectual deficits in Parkinson disease. Neurology 1982; 32 (2): 133-137
36. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114 (Pt 5): 2095-2122
37. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997; 244 (1): 2-8
38. Muller U, Wachter T, Barthel H, Reuter M, Cramon DY von. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm 2000; 107 (3): 303-319
39. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain 1992; 115 (Pt 6): 1701-1725
40. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 1992; 107 (2-3): 394-404
41. Hietanen M, Teravainen H. Dementia and treatment with L-dopa in Parkinson's disease. Mov Disord 1988; 3 (3): 263-270
42. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57 (1): 79-88
43. Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990; 47 (7): 747-752
44. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995; 58 (5): 598-606
45. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW. Executive and mnemonic functions in early Huntington's disease. Brain 1996; 119 (Pt 5): 1633-1645
46. Backman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997; 120 (Pt 12): 2207-2217
47. Morice R, Delahunty A. Frontal/executive impairments in schizophrenia. Schizophr Bull 1996; 22 (1): 125-137
48. Heinrichs RW, Awad AG. Neurocognitive subtypes of chronic schizophrenia. Schizophr Res 1993; 9 (1): 49-58
49. Velligan DI, Bow-Thomas CC. Executive function in schizophrenia. Semin Clin Neuropsychiatry 1999; 4 (1): 24-33
50. Evans JJ, Chua SE, McKenna PJ, Wilson BA. Assessment of the dysexecutive syndrome in schizophrenia. Psychol Med 1997; 27 (3): 635-646
51. Franke P, Maier W, Hain C, Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia? Schizophr Res 1992; 6 (3): 243-249
52. Cannon TD, Huttunen MO, Lonnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, Finkelstein J, Hietanen M, Kaprio J, Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet 2000; 67 (2): 369-382
53. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001 ; 50 (11): 825-844
54. Pantelis C, Maruff P. The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. J Psychosom Res 2002; 53 (2): 655-664
55. Kolb B, Whishaw IQ. Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients. J Nerv Ment Dis 1983; 171 (7): 435-443
56. Morrison-Stewart SL, Williamson PC, Corning WC, Kutcher SP, Snow WG, Merskey H. Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia. Psychol Med 1992; 22 (2): 353-359
57. Morris RG, Rushe T, Woodruffe PW, Murray RM. Problem solving in schizophrenia: a specific deficit in planning ability. Schizophr Res 1995; 14 (3): 235-246
58. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992; 49 (12): 975-982
59. Wexler BE, Stevens AA, Bowers AA, Sernyak MJ, Goldman-Rakic PS. Word and tone working memory deficits in schizophrenia. Arch Gen Psychiatry 1998; 55 (12): 1093-1096
60. Pearlson GD, Marsh L. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry 1999; 46 (5): 627-649
61. Falkai P, Vogeley K, Maier W. Hirnstrukturelle Veränderungen bei Patienten mit schizophrenen Psychosen - Von der fokalen Pathologie zur Netzwerkstörung. Nervenarzt 2001; 72 (5): 331-341
62. Weinberger DR, Berman KF, Zee RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43 (2): 114-124
63. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998; 155 (9): 1285-1287
64. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, Sharma TS, Murray RM, McGuire PK. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 1998; 155 (8): 1056-1063
65. Orzack MH, Kornetsky C. Attention dysfunction in chronic schizophrenia. Arch Gen Psychiatry 1966; 14: 323-326
66. Hepp HH, Maier S, Hermle L, Spitzer M. The Stroop effect in schizophrenic patients. Schizophr Res 1996; 22 (3): 187-195
67. Wykes T, Reeder C, Corner J. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia. Schizophr Res 2000; 46 (2-3): 241-253
68. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry 2000; 57 (5): 471-480
69. Wilder KE, Weinberger DR, Goldberg TE. Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning. Schizophr Res 1998; 30 (2): 169-174
70. Hutton SB, Murphy FC, Joyce EM, Rogers RD, Cuthbert I, Barnes TR, McKenna PJ, Sahakian BJ, Robbins TW. Decision making deficits in patients with first-episode and chronic schizophrenia. Schizophr Res 2002; 55 (3): 249-257
71. 2O PET study during single-trial Stroop task performance. Am J Psychiatry 1997; 154 (12): 1670-1675
72. Rubia K, Russell T, Bullmore ET, Soni W, Brammer MJ, Simmons A, Taylor E, Andrew C, Giampietro V, Sharma T. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res 2001; 52 (1-2): 47-55
73. Fallgatter AJ, Muller TJ. Electrophysiological signs of reduced prefrontal response control in schizophrenic patients. Psychiatry Res 2001; 107(1): 19-28
74. Weisbrod M, Kiefer M, Marzinzik F, Spitzer M. Executive control is disturbed in schizophrenia: evidence from event-related potentials in a Go/NoGo task. Biol Psychiatry 2000; 47 (1): 51-60
75. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992; 149 (7): 898-903
76. Hutton SB, Puri BK, Duncan LJ, Robbins TW, Barnes TR, Joyce EM. Executive function in first-episode schizophrenia. Psychol Med 1998; 28 (2): 463-473
77. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998; 24 (3): 425-435
78. Medalia A, Gold JM, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology 1988; 3: 249-271
79. Verdoux H, Magnin E, Bourgeois M. Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr Res 1995; 14 (2): 133-139
80. Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999; 25 (2): 201-222
81. Nieuwenstein MR, Aleman A, de Haan EH. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting-Test. Continuous Performance-Test. J Psychiatr Res 2001; 35 (2): 119-125
82. Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, O'Neil S, Mathew V, Sharma T. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2002; 59 (2-3): 137-146
83. Robbins TW. The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull 1990; 16 (3): 391-402
84. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter Jr WT. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994; 51 (10): 804-811
85. Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 1999; 46 (1): 40-55
86. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Heertum R van, Gorman JM, Laruelle M. Prefrontal dopamine D1-receptors and working memory in schizophrenia. J Neurosci 2002; 22 (9): 3708-3719
87. Friston KJ. The disconnection hypothesis. Schizophr Res 1998; 30 (2): 115-125
88. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997; 120 (Pt 10): 1823-1843
89. Jaeger J, Douglas E. Neuropsychiatric rehabilitation for persistent mental illness. Psychiatr Q. 1992; 63 (1): 71-94
90. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153 (3): 321-330
91. Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res 1997; 25 (1): 21-31
92. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48 (3): 239-246
93. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 1999; 25 (2): 309-319
94. Chowdhury R, Ferrier IN, Thompson JM. Cognitive dysfunction in bipolar disorder. Curr Opin Psychiatry 2003; 16: 7-12
95. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-206
96. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001; 3 (3): 106-150; discussion 151-153
97. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological function in young patients with unipolar major depression. Psychol Med 1997; 27 (6): 1277-1285
98. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting-Test performance. Am J Psychiatry 1999; 156 (5): 780-782
99. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003; 182 (3): 214-220
100. Landro NI, Stiles TC, Sletvold H. Neuropsychological function in non-psychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14 (4): 233-240
101. videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000; 101 (1): 11-20
102. Trichard C, Martinot JL, Alagille M, Masure MC, Hardy P, Ginestet D, Feline A. Time course of prefrontal lobe dysfunction in severely depressed in patients: a longitudinal neuropsychological study. Psychol Med 1995; 25 (1): 79-85
103. Kaiser S, Linger J, Kiefer M, Markela J, Mundt C, Weisbrod M. Executive Control Deficit in Depression: Event-Related Potentials in a Go/Nogo Task. Psychiatry Res Neuroimaging 2003; 122:169-184
104. Degl'Innocenti A, Agren H, Backman L. Executive deficits in major depression. Acta Psychiatr Scand 1998; 97 (3): 182-188
105. Austin MP, Mitchell P, Wilhelm K, Parker G, Hickie I, Brodaty H, Chan J, Eyers K, Milic M, Hadzi-Pavlovic D. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol Med 1999; 29(1): 73-85
106. Dolan RJ, Bench CJ, Liddle PF, Friston KJ, Frith CD, Grasby PM, Frackowiak RS. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? J Neurol Neurosurg Psychiatry 1993; 56 (12): 1290-1294
107. Dolan RJ, Bench CJ, Brown RG, Scott LC, Frackowiak RS. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood now. Psychol Med 1994; 24 (4): 849-857
108. Borkowska A, Rybakowski JK. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord 2001; 3 (2): 88-94
109. Neu P, Kiesslinger U, Schlattmann P, Reischies FM. Time-related cognitive deficiency in four different types of depression. Psychiatry Res 2001; 103 (2-3): 237-247
110. Lockwood KA, Alexopoulos GS, Gorp WG van. Executive dysfunction in geriatric depression. Am J Psychiatry 2002; 159 (7): 1119-1126
111. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002; 72 (3): 209-226
112. Morice R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990; 157: 50-54
113. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158 (10): 1605-1611
114. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES, Robbins TW, Sahakian BJ. Decision-making in mania: a PET study. Brain 2001; 124 (Pt 12): 2550-2563
115. Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997; 185 (12): 748 -754
116. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319
117. Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001; 102 (1): 9-20
118. Martinez-Aran A, Penades R, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gasto C. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2002; 71 (1): 39-46
119. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57 (3): 285-290
120. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 2000; 60(1): 13-23
121. Kaiser S, Mundt C, Weisbrod M. Störung der exekutiven Kontrollfunktionen bei depressiven Patienten - Implikationen für die Psychotherapie. In: Schiepek G (Hrsg). Neurobiologie der Psychotherapie. Stuttgart: Schattauer, 2003
122. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41 (1): 86-106
123. Ebert D, Lammers C-H. Das zentrale dopaminerge System und die Depression. Nervenarzt 1999; 68: 545-555
124. Modell JG, Mountz JM, Curtis GC, Greden JF. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1989; 1 (1): 27-36
125. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998; (35): 26-37
126. Anderson KE, Savage CR. Cognitive and neurobiological findings in obsessive-compulsive disorder. Psychiatr Clin North Am 2004; 27 (1): 37-47, viii
127. Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol 2004; 65 (3): 185-236
128. Evans DW, Lewis MD, lobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn 2004; 55 (1): 220-234
129. Basso MR, Bornstein RA, Carona F, Morton R. Depression accounts for executive function deficits in obsessive-compulsive disorder. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14 (4): 241-245
130. Mataix-Cols D, Alonso P, Pifarre J, Menchon JM, Vallejo J. Neuropsychological performance in medicated vs. unmedicated patients with obsessive-compulsive disorder. Psychiatry Res 2002; 109 (3): 255-264
131. Nielen MM, Den Boer JA. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Psychol Med 2003; 33 (5): 917-925
132. Kunert HJ, Druecke HW, Sass H, Herpertz SC. Frontal lobe dysfunctions in borderline personality disorder? Neuropsychological findings. J Personal Disord 2003; 17 (6): 497-509
133. Monarch ES, Saykin AJ, Flashman LA. Neuropsychological impairment in borderline personality disorder. Psychiatr Clin North Am 2004; 27 (1): 67-82, viii-ix
134. Bazanis E, Rogers RD, Dowson JH, Taylor P, Meux C, Staley C, Nevinson-Andrews D, Taylor C, Robbins TW, Sahakian BJ. Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder. Psychol Med 2002; 32 (8): 1395-1405
135. Rentrop M, Unger J, Weisbrod M, Renneberg B. Response Inhibition in Borderline Personality Disorder: Performance in a Go/Nogo task. Eingereicht,
136. Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 2003; 123 (3): 153-163
137. Brower MC, Price BH. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review. J Neurol Neurosurg Psychiatry 2001; 71 (6): 720-726
138. Dolan M, Park I. The neuropsychology of antisocial personality disorder. Psychol Med 2002; 32 (3): 417-427
139. Vollm B, Richardson P, Stirling J, Elliott R, Dolan M, Chaudhry I, Del Ben C, McKie S, Anderson I, Deakin B. Neurobiologrcal substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study. Crim Behav Ment Health 2004; 14 (1): 39-54
140. Coull JT. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol 1998; 55 (4): 343-361
141. Robbins TW. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 2000; 133 (1): 130-138
142. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 2002; 67 (1): 53-83
143. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 1999; 96 (23): 13432-13437
144. Marin RS. Apathy: Concept, Syndrome, Neural Mechanisms, and Treatment. Semin Clin Neuropsychiatry 1996; 1 (4): 304-314
145. Meltzer HY, Park S, Kessler R. Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc Natl Acad Sci U S A 1999; 96 (24): 13591-13593
146. Friedman JI, Temporini H, Davis KL Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 1999; 45 (1): 1-16
147. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 1991; 40 (3): 657-671
148. Muller U, Cramon DY von, Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 1998; 18 (7): 2720-2728
149. Roesch-Ely D, Scheffel H, Weiland S, Schwaninger M, Hundemer HP, Kolter T, Witte S, Weisbrod M. Dopaminergic Modulation of PFC functions in schizophrenic patients. Eingereicht,
150. Kimberg DY, D'Esposito M, Farah MJ. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 1997; 8 (16): 3581-3585
151. Harvey PD, Keefe RS. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 2001; 158(2): 176-184
152. Richelson E. Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin Proc 1994; 69 (11): 1069-1681
153. 2- noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53 (5): 448-455
154. Moffoot A, O'Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM. Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff s psychosis. Psychol Med 1994; 24 (1): 53-61
155. Fields RB, Kammen DP van, Peters JL, Rosen J, Kammen WB van, Nugent A, Stipetic M, Linnoila M. Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings. Schizophr Res 1988; 1 (6): 417-423
156. Ferguson JM, Wesnes KA, Schwartz GE. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol 2003; 18 (1): 9-14
157. Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999; 21 (2 Suppl): 106S-115S
158. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) 1999; 146 (4): 482-491
159. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997; 20 (2): 427-451
160. Hollander E, Rosen J. Impulsivity. J Psychopharmacol 2000; 14 (2 Suppl 1): S39-44
161. Kopelman MD. The cholinergic neurotransmitter system in human memory and dementia: a review. Q J Exp Psychol A 1986; 38 (4): 535-573
162. Everitt B, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol 1996; 48: 649-684
163. Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 2003; 11 (2): 131-145
164. Amenta F, Di Tullio MA, Tomassoni D. The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies. Clin Exp Hypertens 2002; 24 (7-8): 697-713
165. Griffin SL, Reekum R van, Masanic C. A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. J Neuropsychiatry Clin Neurosci 2003; 15 (1): 17-26
166. Mateer CA. Executive function disorders: rehabilitation challenges and strategies. Semin Clin Neuropsychiatry 1999; 4 (1): 50-59
167. Gauggel S. Neuropsychologische Therapie der Frontalhirnstörung: Therapieprogramme. In: Foerstl H (Hrsg). Der Frontallappen. Funktionen und Erkrankungen. Berlin: Springer, 2002
168. Backman L, Dixon RA. Psychological compensation: a theoretical framework. Psychol Bull 1992; 112 (2): 259-283
169. Campbell 3rd JJ, Duffy JD, Salloway SP. Treatment strategies for patients with dysexecutive syndromes. J Neuropsychiatry Clin Neurosci 1994; 6 (4): 411-418
170. Sohlberg MM, Mateer C. Cognitive Rehabilitation - An Integrative Neuropsychological Approach. New York: Guilford Press, 2001
171. Baddeley AD. Implicit memory and errorless learning: a link between cognitive theory and neuropsychological rehabilitation? In: Squire LR, Buttes N (Hrsg). Neuropsychology of memory. 2. Aufl. New York: Guilford, 1992: 309-314
172. Kern RS, Liberman RP, Kopelowicz A, Mintz J, Green MF. Applications of errorless learning for improving work performance in persons with schizophrenia. Am J Psychiatry 2002; 159 (11): 1921-1926
173. Meichenbaum D. The potential contributions of cognitive behavior modification to the rehabilitation of individuals with traumatic brain injury. Semin Speech Lang 1993; 14 (1): 18-31
174. Cicerone KD, Giacino JT. Remediation of executive function deficits. Neurorehabilitation 1992; 2: 73-83
175. Cramon DY von, Matthes-von Cramon G. Back to work with a chronic dysexecutive syndrome? A case report. Neuropsychol Rehab 1994; 4: 399-417
176. Alderman N, Fry RK, Youngson HA. Improvement of self-monitoring skills, reduction of behavior disturbance and the dysexecutive syndrome: Comparison of response cost and a new programme of self-monitoring training. Neuropsychol Rehab 1995; 5: 193-221
177. Robertson IH, Murre JM. Rehabilitation of brain damage: brain plasticity and principles of guided recovery. Psychol Bull 1999; 125 (5): 544-575
178. Cramon DY von, Matthes-von Cramon G, Mai N. Problem-solving deficits in brain-injured patients: A therapeutic approach. Neuropsychological Rehabilitation 1991; 1: 45-64
179. Sohlberg MM, Mateer C. Introduction to cognitive rehabilitation. New York: Guilford, 1989
180. Vauth R, Dietl M, Stieglitz RD, Olbrich HM. Kognitive Remediation - Eine neue Chance in der Rehabilitation schizophrener Störungen? Nervenarzt 2000; 71 (1): 19-29
181. Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr Bull 1999; 25 (2): 257-274
182. Delahunty A, Morice R. Rehabilitation of frontal/executive impairments in schizophrenia. Aust N Z J Psychiatry 1996; 30 (6): 760-767
183. Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull 1999; 25 (2): 291-307
184. Stablum F, Umilta C, Mogentale C, Carlan M, Guerrini C. Rehabilitation of executive deficits in closed head injury and anterior communicating artery aneurysm patients. Psychological Research 2000; 63: 265-278
185. Sohlberg MM, Raskin S. Principles of generalization applied to attention and memory interventions. Journal of Head Trauma Rehabilitation 1996; 11 (2): 65-78
186. Grant DA, Berg EA. A behavioral analysis of the degree of reinforcement and ease of shifting to new responses in a Weigl-type card sorting problem. J Exp Psychol 1948; 38: 404-411
187. Milner B. Effects of different brain lesions on card sorting. Arch Neurol 1963; 9: 90-100
188. Jones-Gotman M, Milner B. Design fluency: the invention of nonsense drawings after focal cortical lesions. Neuropsychologia 1977; 15: 633-674
189. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982; 298: 199-209
190. Porteus SD. Porteus Maze Test: Fifty Years' Application. Palo Alto: Pacific Books, 1965
191. Oscar-Berman M, McNamara P, Freedman M. Delayed-response tasks: parallels between experimental ablation studies and findings in patients with frontal lesions. In: Benton A (Hrsg). Frontal Lobe Function and Dysfunction. New York: Oxford University Press, 1991: 256-272
192. Nystrom LE, Braver TS, Sabb FW, Delgado MR, Noll DC, Cohen JD. Working memory for letters, shapes, and locations: fMRI evidence against stimulus-based regional organization in human prefrontal cortex. Neuroimage 2000; 11 (5 Pt 1): 424-446
193. Rosvold HE, Mirsky A, Sarason I, Bransomejr ED, Beck LH. A continuous performance test of brain damage. Journal of Consulting Psychology 1956; 20: 343-350
194. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662
195. Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc 1992; 40 (12): 1221-1226
196. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998; 64 (5): 588-594
197. Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills 1992; 74 (3 Pt 1): 883-892
198. Grace J, Stout JC, Malloy PF. Frontal Systems Behavior Scale: Professional manual. Lutz, Florida: Psychological Assessment Resources, 2001
199. Braswell D, Hartry A, Hoornbeek S, Johansen A, Johnson L, Schultz J, Sohlberg MM. Profile of the Executive Control System. Wake Forest: Lash & Associates, 1993
200. Gauggel S, Deckersbach T, Rolko C. Entwicklung und erste Evaluation einer Skala zur Beurteilung von Handlungs-, Planungs- und Problemlösestö rungen. Z Neuropsychol 1998; 11 (3): 159-171
201. Pechtold K, Jankowski P. Handeln lernen. München: Urban & Fischer, 2000
202. Wilson BA, Aldermann N, Burgess PW et al. The Behavioural Assessment of the Dysexecutive Syndrome. Flempton: Thames Valley Test Company, 1996
203. Ettlin TM, Kischka U, Beckson M, Gaggiotti M, Rauchfleisch U, Benson DF. The Frontal Lobe Score: part I: construction of a mental status of frontal systems. Clin Rehabil 2000; 14 (3): 260-271